Obstetrics, Gynecology & Reproductive Sciences
At Yale Medicine, our clinicians benefit from the extensive expertise within our clinical practice, allowing them to provide personalized care for patients from adolescence through adulthood. Our team specializes in a variety of subspecialty areas, covering all aspects of women’s health, including family planning, oncology, specialized gynecology, maternal–fetal medicine, midwifery, and reproductive endocrinology.
Our recent clinical research highlights our innovative approach to patient care. This includes a focus on therapeutic vaccines in gynecologic oncology, groundbreaking treatments for endometriosis and menopause, a comprehensive patient safety program in maternal–fetal medicine, and a cutting-edge fetal therapy program.
Distinguishing Factors
- Maternal–fetal medicine service offers 24-hour on-site dedicated space for complex pregnancies and fetal care
- First in Connecticut to perform in-utero laser therapy in pregnancies complicated by twin-to-twin transfusion syndrome
- Outstanding survival outcomes for all types of gynecologic surgery, from open to robotic
- Pioneer in caring for patients with sexual intimacy issues after cancer surgery
- Fetal therapy program
- Midwifery and birthing center
A global leader in women’s health, Yale Medicine is known for its innovative contributions to diagnosis and treatment, including:
- Developing the first fetal echocardiography
- Pioneering the first obstetrical ultrasound
- Developing the first fetal blood sampling and first fetal transfusion
- Offering the first chorionic villus sampling in New England
- Co-authoring the first U.S. study for first-trimester risk assessment
- Developing the first comprehensive first-trimester risk assessment program in New England
- Inventing fetal monitoring and many prenatal diagnostic and treatment techniques
Our Programs
Fact Sheets
News
Clinical Trials
A Historical Cohort, Multicenter Study to Characterize the Management, Clinical Course, and Outcomes of Pregnancies in Women Who Have Experienced a Pregnancy With Early Onset Severe HDFN
- Gynecological Cancers
A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]